References
- 1AUTM. 2007. In the Public Interest: Nine Points to Consider in Licensing University Technology. Washington, DC.
- 2Borda, A, Gray, K and Fu, Y. 2019. Research data management in health and biomedical citizen science: Practices and prospects. JAMIA Open, 3(1): 113–125. DOI: 10.1093/jamiaopen/ooz052
- 3Bowser, A, Cooper, C, de Sherbinin, A, Wiggins, A, Brenton, P, Chuang, T-R, Faustman, E, Haklay, M and Meloche, M. 2020. Still in need of norms: The state of the data in citizen science. Citizen Science: Theory and Practice, 5(1): 18. DOI: 10.5334/cstp.303
- 4Chesser, S, Porter, MM and Tuckett, AG. 2020. Cultivating citizen science for all: Ethical considerations for research projects involving diverse and marginalized populations. International Journal of Social Research Methodology, 23(5): 497–508. DOI: 10.1080/13645579.2019.1704355
- 5Cooper, CB, Rasmussen, LM and Jones, ED. 2021. The power (dynamics) of open data in citizen science. Frontiers in Climate, 3:
637037 . DOI: 10.3389/fclim.2021.637037 - 6Cooper, S, Khatib, F, Treuille, A, Barbero, J, Lee, J, Beenen, M, Leaver-Fay, A, Baker, D, Popovic, Z and Foldit players. 2010. Predicting protein structures with a multiplayer online game. Nature, 466: 756–760. DOI: 10.1038/nature09304
- 7Curtis, V. 2015. Motivation to participate in an online citizen science game: A study of Foldit. Science Communication, 37(6): 723–746. DOI: 10.1177/1075547015609322
- 8Damiani, R, Krieger, JL, Treise, D, Walsh-Childers, K, Fisher, CL, Bloodworth, S, Brishke, J and Shenkman, E. 2021. Learning the language of science: A pilot study exploring citizen scientists’ identity and communication with researchers. Journal of Clinical and Translational Science, 5: e208. DOI: 10.1017/cts.2021.847
- 9Del Savio, L, Prainsack, B and Buyx, A. 2017. Motivations of participants in the citizen science of microbiomics: Data from the British Gut Project. Genetics in Medicine, 19(8): 959–961. DOI: 10.1038/gim.2016.208
- 10Dratwa, J. (ed.) 2015. Opinion No. 29 of the European Group on Ethics in Science and New Technologies to the European Commission: The Ethical Implications of New Health Technologies and Citizen Participation. Brussels, BE.
- 11Eterna. n.d.a. How it works. Available at
https://eternagame.org/about . (Last accessed 22 May 2022). - 12Eterna. n.d.b. Publications. Available at
https://eternagame.org/publications . (Last accessed 22 May 2022). - 13European Citizen Science Association (ECSA). 2015. Ten principles of citizen science. Available at
https://ecsa.citizen-science.net/documents/ . (Last accessed 19 May 2022). - 14European Citizen Science Association (ECSA). 2020. ECSA’s characteristics of citizen science: Explanation notes. Available at
https://ecsa.citizen-science.net/wp-content/uploads/2020/05/ecsa_characteristics_of_citizen_science_explanation_notes_-_v1_final.pdf . (Last accessed 19 May 2022). - 15Evans, BJ. 2020. The perils of parity: Should citizen science and traditional research follow the same ethical and privacy principles? Journal of Law, Medicine & Ethics, 48(S1): 74–81. DOI: 10.1177/1073110520917031
- 16Fiske, A, Del Savio, L, Prainsack, B and Buyx, A. 2019.
Conceptual and ethical considerations for citizen science in biomedicine . In: Heyen, NB, Dickel, S, and Bruninghaus, A (eds.), Personal Health Science, 195–217. Wiesbaden: Springer. DOI: 10.1007/978-3-658-16428-7_10 - 17Fiske, A, Prainsack, B and Buyx, A. 2019. Meeting the needs of underserved populations: Setting the agenda for more inclusive citizen science of medicine. Journal of Medical Ethics, 45: 617–622. DOI: 10.1136/medethics-2018-105253
- 18Gallegos, JE, Boyer, C, Pauwels, E, Kaplan, WA and Peccoud, J. 2018. The Open Insulin Project: A case study for ‘biohacked’ medicines. Trends in Biotechnology, 36(12): 1211–1218. DOI: 10.1016/j.tibtech.2018.07.009
- 19Genes in Space. n.d.a. FAQ: Where can I find information about previous finalists? Available at
https://www.genesinspace.org/us-contest/ . (Last accessed 23 May 2022). - 20Genes in Space. n.d.b. Alumni. Available at
https://www.genesinspace.org/meet-us/ . (Last accessed 23 May 2022). - 21Grant, AD, Wolf, GI and Nebeker, C. 2019. Approaches to governance of participant-led research: A qualitative case study. BMJ Open, 9:
e025633 . DOI: 10.1136/bmjopen-2018-025633 - 22Greely, HT. 2020. The future of DTC genomics and the law. Journal of Law, Medicine & Ethics, 48: 151–160. DOI: 10.1177/1073110520917003
- 23Greenberg v. Miami Children’s Hospital Research Institute. 2003. Southern District of Florida. 264 F. Supp.
2nd 1064. - 24Greshake, B, Bayer, PE, Rausch, H and Reda, J. 2014. openSNP–A crowdsourced web resource for personal genomics. PLoS One, 9(3):
e89204 . DOI: 10.1371/journal.pone.0089204 - 25Groot, B and Abma, T. 2022. Ethics framework for citizen science and public and patient participation in research. BMC Medical Ethics, 23: 23. DOI: 10.1186/s12910-022-00761-4
- 26Guerrini, CJ and Contreras, JL. 2020. Credit for and control of research outputs in genomic citizen science. Annual Review of Genomics and Human Genetics, 21: 465–489. DOI: 10.1146/annurev-genom-083117-021812
- 27Guerrini, CJ, Contreras, JL, Bash Brooks, W, Canfield, I, Trejo, M and McGuire, AL. 2022. “Idealists and capitalists”: Ownership attitudes and preferences in genomic citizen science. New Genetics and Society, 41(2): 74–95. DOI: 10.1080/14636778.2022.2063827
- 28Guerrini, CJ, Lewellyn, M, Majumder, MA, Trejo, M, Canfield, I and McGuire, AL. 2019. Donors, authors, and owners: How is genomic citizen science addressing interests in research outputs? BMC Medical Ethics, 20: 84. DOI: 10.1186/s12910-019-0419-1
- 29Guerrini, CJ, Majumder, MA, Lewellyn, MJ and McGuire, AL. 2018. Citizen science, public policy. Science, 361(6398): 134–136. DOI: 10.1126/science.aar8379
- 30Harvard Personal Genome Project (PGP). 2022. Consent form. Rev. 2017.04.21.
- 31Just One Giant Lab (JOGL). 2022. How it works. Available at
https://jogl.io/ . (Last accessed 10 September 2022). - 32Kasperowski, D, Hagen, N and Rohden, F. 2021. Ethical boundary work in citizen science: Themes of insufficiency. Nordic Journal of Science and Technology Studies, 9(2): 13–24. DOI: 10.5324/njsts.v10i1.4318
- 33Land-Zandstra, AM, van Beusekom, MM, Koppeschaar, CE and van den Broek, JM. 2016. Motivation and learning impact of Dutch flu-trackers. Journal of Science Communication, 15(01): A04. DOI: 10.22323/2.15010204
- 34Lee, J, Kladwang, W, Lee, M, Cantu, D, Azizyan, M, Kim, H, Limpaecher, A, Gaikwad, S, Yoon, S, Treuille, A, Das, R and EteRNA participants. 2014. RNA design rules from a massive open laboratory. Proceedings of the National Academy of Sciences, 111(6): 2122–2127. DOI: 10.1073/pnas.1313039111
- 35Meyer, MN. 2020. There oughta be a law: When does(n’t) the U.S. Common Rule apply? Journal of Law, Medicine & Ethics, 48(S1): 60–73. DOI: 10.1177/1073110520917030
- 36Millum, J. 2012. Sharing the benefits of research fairly: Two approaches. Journal of Medical Ethics, 38: 219–223. DOI: 10.1136/medethics-2011-100118
- 37National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (National Commission). 1979. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC.
- 38O’Donnell, S, Lewis, D, Marchante Fernández, M, Wäldchen, M, Cleal, B, Skinner, T, Raile, K, Tappe, A, Ubben, T, Willaing, I, Hauck, B, Wolf, S and Braune, K. 2019. Evidence on user-led innovation in diabetes technology (The OPEN Project): Protocol for a mixed methods study. JMIR Research Protocols, 8(11):
e15368 . DOI: 10.2196/15368 - 39Pearlman, A. 2019. Biohackers are pirating a cheap version of a million-dollar gene therapy. MIT Technology Review. Available at
https://www.technologyreview.com/2019/08/30/133193/biohackers-are-pirating-a-cheap-version-of-a-million-dollar-gene-therapy/ . (Last accessed 10 September 2022). - 40Rasmussen, LM. 2019. Beyond Belmont—and beyond regulations. The American Journal of Bioethics, 19(8): 19–21. DOI: 10.1080/15265161.2019.1619879
- 41Rasmussen, LM. 2021.
Research ethics in citizen science . In: Iltis, AS and MacKay, D (eds.), The Oxford Handbook of Research Ethics. Oxford, UK: Oxford University Press. DOI: 10.1093/oxfordhb/9780190947750.013.36 - 42Resnik, DB. 2019. Institutional review board oversight of citizen science research involving human subjects. The American Journal of Bioethics, 19(8): 21–23. DOI: 10.1080/15265161.2019.1619864
- 43Resnik, DB, Elliott, KC and Miller, AK. 2015. A framework for addressing ethical issues in citizen science. Environmental Science & Policy, 54: 475–481. DOI: 10.1016/j.envsci.2015.05.008
- 44Rid, A and Wendler, D. 2011. A framework for risk-benefit evaluations in biomedical research. Kennedy Institute of Ethics Journal, 21(2): 141–179. DOI: 10.1353/ken.2011.0007
- 45Riesch, H and Potter, C. 2014. Citizen science as seen by scientists: Methodological, epistemological and ethical dimensions. Public Understanding of Science, 23(1): 107–120. DOI: 10.1177/0963662513497324
- 46Roberts, JL. 2017. Negotiating commercial interests in biospecimens. Journal of Law, Medicine & Ethics, 45: 138–141. DOI: 10.1177/1073110517703107
- 47Roberts, JL, Pereira, S and McGuire, AL. 2017. Should you profit from your genome? Nature Biotechnology, 35(1): 18–20. DOI: 10.1038/nbt.3757
- 48Ross-Hellauer, T, Tennant, JP, Banelytė, V, Gorogh, E, Luzi, D, Kraker, P, Pisacane, L, Ruggieri, R, Sifacaki, E and Vignoli, M. 2020. Ten simple rules for innovative dissemination of research. PLoS Computational Biology, 16(4):
e1007704 . DOI: 10.1371/journal.pcbi.1007704 - 49Scassa, T and Chung, H. 2015a. Managing Intellectual Property Rights in Citizen Science: A Guide for Researchers and Citizen Scientists. Woodrow Wilson International Center for Scholars, Washington, DC.
- 50Scassa, T and Chung, H. 2015b. Typology of Citizen Science Projects from an Intellectual Property Perspective: Invention and Authorship Between Researchers and Participants. Woodrow Wilson International Center for Scholars, Washington, DC.
- 51Smith, E, Bélisle-Pipon, J-C and Resnik, D. 2019. Patients as research partners; How to value their perceptions, contribution and labor? Citizen Science: Theory and Practice, 4(1): 15. DOI: 10.5334/cstp.184
- 52Spector-Bagdady, K, De Vries, RG, Gornick, MG, Shuman, AG, Kardia, S and Platt, J. 2018. Encouraging participation and transparency in biobank research. Health Affairs, 37(8): 1313–1320. DOI: 10.1377/hlthaff.2018.0159
- 53Thorogood, A, Bobe, J, Prainsack, B, Middleton, A, Scott, E, Nelson, S, Corpas, M, Bonhomme, N, Rodriguez, LL, Murtagh, M and Kleiderman, E. 2018. APPLaUD: Access for patients and participants to individual level uninterpreted genomic data. Human Genomics, 12: 7. DOI: 10.1186/s40246-018-0139-5
- 54Torkamani, A, Wineinger, NE and Topol, EJ. 2018. The personal and clinical utility of polygenic risk scores. Nature Reviews Genetics, 19: 581–590. DOI: 10.1038/s41576-018-0018-x
- 55Trejo, M, Canfield, I, Robinson, JO and Guerrini, CJ. 2021. How biomedical citizen scientists define what they do: It’s all in the name. AJOB Empirical Bioethics, 12(1); 63–70. DOI: 10.1080/23294515.2020.1825139
- 56U.S. Department of Health and Human Services (HHS). (n.d.) Informed consent FAQs: When does compensating subjects undermine informed consent or parental permission? Available at
https://www.hhs.gov/ohrp/regulations-and-policy/guidance/faq/informed-consent/index.html . (Last accessed 14 September 2022). - 57U.S. Department of Health and Human Services (HHS). 2017. Final rule. Federal policy for the protection of human subjects. Federal Register, 82(12): 7149–7274.
- 58U.S. Food and Drug Administration (FDA). 2019a. Draft guidance for industry and Food and Drug Administration staff. Clinical decision support software. Available at
https://www.fda.gov/media/109618/download . (Last accessed 1 May 2022). - 59U.S. Food and Drug Administration (FDA). 2019b. Guidance for industry and Food and Drug Administration staff. General wellness: Policy for low-risk devices. Available at
https://www.fda.gov/media/90652/download . (Last accessed 18 May 2022). - 60Vayena, E and Tasioulas, J. 2013. Adapting standards: Ethical oversight of participant-led health research. PLoS Medicine, 10(3):
e1001402 . DOI: 10.1371/journal.pmed.1001402 - 61Vayena, E and Tasioulas, J. 2015. “We the scientists”: A human right to science. Philosophy and Technology, 28: 479–485. DOI: 10.1007/s13347-015-0204-0
- 62Wertheimer, A. 2013. Is payment a benefit? Bioethics, 27(2): 105–116. DOI: 10.1111/j.1467-8519.2011.01892.x
- 63White, L. 2019. A neglected ethical issue in citizen science and DIY biology. The American Journal of Bioethics, 19(8): 46–48. DOI: 10.1080/15265161.2019.1619876
- 64Wicks, P, Vaughan, TE, Massagli, MP and Heywood, J. 2011. Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm. Nature Biotechnology, 29(5): 411–414. DOI: 10.1038/nbt.1837
- 65Wiggins, A and Wilbanks, J. 2019. The rise of citizen science in health and biomedical research. The American Journal of Bioethics, 19(8): 3–14. DOI: 10.1080/15265161.2019.1619859
- 66Wolf, SM. 2020. Return of results in participant-driven research: Learning from transformative research models. Journal of Law, Medicine & Ethics, 48(S1): 159–166. DOI: 10.1177/1073110520917042
- 67Woolley, JP, McGowan, ML, Teare, HJA, Coathup, V, Fishman, JR, Settersten
Jr. , RA, Sterckx, S, Kaye, J and Juengst, ET. 2016. Citizen science or scientific citizenship? Disentangling the uses of public engagement rhetoric in national research initiatives. BMC Medical Ethics, 17: 33. DOI: 10.1186/s12910-016-0117-1
